Skip to main content
. 2014 May 13;473(1):57–63. doi: 10.1007/s11999-014-3668-9

Table 1.

Comparison of baseline characteristics between matched nonobese and morbidly obese patients

Baseline characteristics Nonobese (n = 90,442) Morbidly obese (n = 90,143) p value*
Number (%) Number (%)
Age (years; mean; range) 61 (22–90) 61 (22–90) NA
Female 67,859 (75) 67,682 (75) 0.79
Comorbidities
 Obstructive sleep apnea 19,249 (21) 19,147 (21) 0.82
 AIDS 0 (NA) 0 (NA) NA
 Alcohol abuse 223 (0.2) 228 (0.2) 0.78
 Deficiency anemia 11,708 (13) 11,697 (13) 0.84
 Rheumatoid arthritis/collagen vascular disease 2528 (2.8) 2525 (2.8) 0.93
 Chronic blood loss anemia 1664 (1.8) 1630 (1.8) 0.61
 Congestive heart failure 2324 (2.6) 2322 (2.6) 0.93
 Chronic pulmonary disease 17,765 (19) 17,670 (19) 0.82
 Coagulopathy 654 (0.7) 641 (0.7) 0.76
 Depression 13,714 (15) 13,680 (15) 0.94
 Diabetes uncomplicated 28,468 (31) 28,340 (31) 0.86
 Diabetes with chronic complications 1950 (2.2) 1929 (2.1) 0.81
 Drug abuse 139 (0.2) 145 (0.2) 0.70
 Hypertension (uncomplicated and complicated) 69,738 (77) 69,580 (77) 0.68
 Hypothyroidism 13,520 (15) 13,513 (15) 0.80
 Liver disease 428 (0.5) 429 (0.5) 0.93
 Lymphoma 56 (0.1) 57 (0.1) 0.91
 Fluid and electrolyte disorder 6367 (7) 6,353 (7) 0.94
 Metastatic cancer 10 (< 0.1) 10 (< 0.1) 0.99
 Other neurological disorders 2122 (2.3) 2078 (2.3) 0.56
 Paralysis 74 (0.1) 77 (0.1) 0.79
 Peripheral vascular disease 851 (0.9) 845 (0.9) 0.93
 Psychoses 1257 (1.4) 1232 (1.4) 0.67
 Pulmonary circulation disorders 538 (0.6) 539 (0.6) 0.93
 Renal failure 1995 (2.2) 1977 (2.2) 0.85
 Solid tumor without metastasis 111 (0.1) 108 (0.1) 0.85
 Peptic ulcer disease excluding bleeding <10 (< 0.1) <10 (< 0.1) 0.99
 Valvular heart disease 2170 (2.4) 2185 (2.4) 0.73
 Weight loss 20 (< 0.1) 19 (< 0.1) 0.88

* Pearson chi square; NA = not applicable.